For the quarter ending 2025-09-30, IMMX has $20,080,604 in assets. $11,815,634 in debts. $15,947,308 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Tax receivable | - | 0 | ||
| Cash and cash equivalents | 15,947,308 | 11,637,945 | ||
| Prepaid expenses and other current assets | 636,972 | 687,515 | ||
| Total current assets | 16,584,280 | 12,325,460 | ||
| Other assets | 20,418 | 20,418 | ||
| Deferred offering cost | 111,689 | 110,606 | ||
| Right-of-use asset, net | 1,005,434 | 947,103 | ||
| Total property and equipment, gross | 2,599,671 | - | ||
| Less accumulated depreciation | 240,888 | - | ||
| Property and equipment excluding construction in progress | 2,358,783 | - | ||
| Property and equipment, net | 2,358,783 | 2,231,517 | ||
| Total assets | 20,080,604 | 15,635,104 | ||
| Accounts payable and accrued expenses | 10,709,299 | 9,939,271 | ||
| Operating lease liability - current | 141,282 | 70,467 | ||
| Total current liabilities | 10,850,581 | 10,009,738 | ||
| Operating lease liability long term | 965,053 | 972,335 | ||
| Total liabilities | 11,815,634 | 10,982,073 | ||
| Common stock, 0.0001 par value 200,000,000 shares authorized 33,107,878 shares issued and 33,035,515 shares outstanding at september 30, 2025 and 27,612,383 shares issued and 27,540,020 shares outstanding at december 31, 2024 | 3,311 | 2,847 | ||
| Additional paid-in capital | 102,074,612 | 90,874,877 | ||
| Accumulated other comprehensive income | 62,464 | 65,032 | ||
| Accumulated deficit | -93,775,454 | -86,189,762 | ||
| Treasury stock at cost, 72,363 shares as of september 30, 2025 and december 31, 2024 | 99,963 | 99,963 | ||
| Total stockholders equity | 8,264,970 | 4,653,031 | ||
| Total liabilities and stockholders equity | 20,080,604 | 15,635,104 | ||
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc. (IMMX)